These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19156121)

  • 1. [Efficacy of memantine in Parkinson's disease with dementia].
    Levin OS; Batukaeva LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):16-23. PubMed ID: 19156121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Perstenev SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):37-42. PubMed ID: 19008850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia.
    Litvinenko IV; Odinak MM; Mogil'naya VI; Perstnev SV
    Neurosci Behav Physiol; 2010 Feb; 40(2):149-55. PubMed ID: 20033305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of memantine in dementia with Lewy bodies].
    Levin OS; Batukaeva LA; Smolentseva IG; Amosova NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(5):39-46. PubMed ID: 18577956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Akatinol memantine in the therapy of cognitive disorders in Parkinson's disease].
    Puzin MN; Krivonos OV; Kozhevnikova ZhV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(1):26-9. PubMed ID: 17310793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
    Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
    Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical rehabilitative effect of memantine on cognitive and motor disorders in patients with Parkinson's disease].
    Li W; Zhao JH; Sun SG; Zhang JW; Suo AQ; Ma MM
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):301-3. PubMed ID: 21419002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.
    Larsson V; Engedal K; Aarsland D; Wattmo C; Minthon L; Londos E
    Dement Geriatr Cogn Disord; 2011; 32(4):227-34. PubMed ID: 22122992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of memantine in dementia associated with Parkinson's disease.
    Leroi I; Overshott R; Byrne EJ; Daniel E; Burns A
    Mov Disord; 2009 Jun; 24(8):1217-21. PubMed ID: 19370737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease.
    Pahwa R; Lyons KE; Hauser RA; Fahn S; Jankovic J; Pourcher E; Hsu A; O'Connell M; Kell S; Gupta S;
    Parkinsonism Relat Disord; 2014 Feb; 20(2):142-8. PubMed ID: 24055014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediate-release formulation in patients with advanced Parkinson's disease: results from an open-label study.
    Takanashi M; Shimo Y; Hatano T; Oyama G; Hattori N
    Drug Res (Stuttg); 2013 Dec; 63(12):639-43. PubMed ID: 23884661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimum dosage of pergolide in patients with Parkinson's disease].
    Neshige R
    Rinsho Shinkeigaku; 2005 Apr; 45(4):328-30. PubMed ID: 15912805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease.
    Schapira AH; Barone P; Hauser RA; Mizuno Y; Rascol O; Busse M; Debieuvre C; Fraessdorf M; Poewe W
    Eur J Neurol; 2013 Jan; 20(1):180-7. PubMed ID: 22845710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Emelin AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):25-33. PubMed ID: 18427456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations.
    Reichmann H; Boas J; Macmahon D; Myllyla V; Hakala A; Reinikainen K;
    Acta Neurol Scand; 2005 Jan; 111(1):21-8. PubMed ID: 15595934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pergolide mesylate can improve sexual dysfunction in patients with Parkinson's disease: the results of an open, prospective, 6-month follow-up.
    Pohanka M; Kanovský P; Bares M; Pulkrábek J; Rektor I
    Eur J Neurol; 2004 Jul; 11(7):483-8. PubMed ID: 15257688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of amantadine sulfate on cognitive disorders in patients with Parkinson's disease].
    Iablonskaia AIu; Fedorova NV; Bel'gusheva ME
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):24-30. PubMed ID: 20639853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effectiveness and quality of life improvement in entacapone-treated Parkinson's disease patients: the effects of an early therapeutic intervention.
    Grandas F; Hernández B;
    Eur J Neurol; 2007 Mar; 14(3):282-9. PubMed ID: 17355548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.